{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Phase II Trial of Eflornithine\/DFMO as Maintenance Therapy for Molecular High Risk\/Very High Risk and Relapsed\/Refractory Medulloblastoma","item":"https:\/\/www.regionalcancercare.org\/trials\/phase-ii-trial-of-eflornithine-dfmo-as-maintenance-therapy-for-molecular-high-risk-very-high-risk-and-relapsed-refractory-medulloblastoma\/#breadcrumbitem"}]}